Ozempic, Wegovy, Mounjaro: what actually sets them apart

This article is educational and does not replace medical consultation. The choice of a drug, its indication and its dose are your doctor's decision.

"Doctor, which is better: Ozempic or Wegovy?" It's one of the questions I'm asked most, and it almost always starts from a reasonable confusion — because brand names are designed to sell, not to explain.

Before comparing anything, you have to understand what is being compared. And the answer often surprises people.

Brand names, not different categories

The first thing worth knowing is that several of those names are the same molecule.

Reference: United States; official prescribing information checked October 16, 2026. This summary covers main uses, not every indication or the full eligibility criteria for each medication.

• Ozempic: semaglutide. One use is improving blood-glucose control in adults with type 2 diabetes.
• Wegovy: semaglutide. Long-term weight management in patients meeting approved criteria. Its label distinguishes injections and tablets; their indications do not fully overlap.
• Mounjaro: tirzepatide. One use is improving blood-glucose control in adults and children aged 10 and older with type 2 diabetes.
• Zepbound: tirzepatide. Weight management in eligible adults; also moderate-to-severe obstructive sleep apnea in adults with obesity.

The links lead to the complete U.S. prescribing information, including indications, contraindications and warnings. Sharing an active ingredient does not make products interchangeable on your own: formulations, regimens and indications may differ.

Approved indications, available names and access conditions vary by country. What is approved where you live does not necessarily match what you read in an article written somewhere else.

When someone asks me whether Ozempic or Wegovy works better, I first clarify that distinction: the same molecule does not mean the same product or indication.

The difference that is real

Between semaglutide and tirzepatide there is a genuine pharmacological difference.

Semaglutide acts on the GLP-1 receptor, one of the hormones the gut releases when you eat, involved in satiety and blood-sugar regulation.

Tirzepatide acts on two pathways: GLP-1 and also GIP, another incretin hormone. That is why it is described as a dual agonist.

That difference in mechanism is real and well documented. What cannot honestly be done is to translate it into a general recommendation that "this one is better for you". Comparative studies exist, and your doctor knows them; what no article can know is your clinical history.

Why I won't tell you which to choose

Not out of legal caution, but because it would be bad medicine.

The choice depends on things a text cannot see: whether your indication is diabetes or weight management, your personal and family history, your kidney and digestive function, what other drugs you take, how you tolerate side effects, what is available and financially sustainable where you live, and how long you intend to use it.

Two people at the same weight can need opposite decisions. That conversation belongs with your doctor, with your history on the table.

A better question than "which is better?"

After walking many people through this process, I've found the most useful question isn't which drug to choose, but what will sustain the result.

Because here the drugs resemble each other more than public conversation suggests: they all reduce appetite, none builds muscle, none teaches you how to eat, and none decides what happens the day you stop.

Questions that pay off more than comparing brands:

• What is the eating plan while appetite is low, so that I don't lose muscle?
• What strength training will I sustain during treatment?
• How will we follow my metabolic markers, not just the weight?
• What is the plan for afterwards? What happens if I stop?
• How do we handle side effects if they appear?

What doesn't change with the brand

With semaglutide, with tirzepatide, or with neither, appropriate nutrition, adapted strength training and sleep can support your health and treatment. That support needs a plan and follow-up suited to your situation.

Habits do not guarantee maintained weight loss after stopping a medication. Treatment duration and any changes should be individualized with the prescribing clinician, with continued follow-up.

That is Amor Consciente applied to a pharmacological decision: not hunting for the right brand, but building the base that makes any tool worth having.

(General education, not medical advice or treatment. Doses and regimens are deliberately not mentioned. Results vary. Approved indications differ between countries. Prescribing, follow-up and any change of treatment belong to a licensed health professional who knows your history. Never start, stop or adjust a medication on your own.)

Author: Dr. Leonardo Vergara. Updated: October 16, 2026.